Study on the Utilization of Egg Shells as CO2 Adsorbent in the Combustion Process of Empty Palm Fruit Bunches

Authors

  • Andrian Putra Pratama Politeknik Negeri Sriwijaya
  • Muhammad Yerizam Politeknik Negeri Sriwijaya
  • Aida Syarif Politeknik Negeri Sriwijaya

DOI:

https://doi.org/10.53893/ijrvocas.v5i2.429

Keywords:

Carbon Dioxide (CO2), Adsorbent, Empty Palm Fruit Bunches, Egg Shells

Abstract

The problem of carbon dioxide (CO2) emissions from the combustion of biomass, such as empty palm fruit bunches (TKKS), is a significant challenge in climate change mitigation efforts. This research aims to examine the effectiveness of eggshells as a CO2 adsorbent in the combustion process of empty palm fruit bunches, and to analyze the effect of adding adsorbent mass on exhaust gas emissions. Eggshells were calcined at 900°C to produce calcium oxide (CaO), then characterized using XRD and Iodine Number tests, and tested in a CO2 adsorption system using gas flow. The XRD test results showed that calcined eggshells have a crystalline structure with a crystalline level of 93.54%, indicating the dominance of CaO compounds as the active component. The Iodine Number test yielded the highest value of 330.018 mg/g at a mass of 2 grams, which indicates good surface area and porosity. CO2 adsorption testing showed that an adsorbent mass of 15 grams was able to reduce CO2 concentration from 974 ppm to 212 ppm, while adding adsorbent mass above 30 grams did not provide a significant reduction due to the increasing initial CO2 concentration. Overall, the results of this study indicate that eggshells have the potential to be an effective, environmentally friendly, and organic waste-based CO2 adsorbent. Their utilization can be an alternative simple carbon capture technology for biomass combustion systems, while also supporting sustainable household waste management.

References

Alimehmeti, I. (2021). Efficacy and Safety of AZD1222, BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2. Albanian Journal Of Trauma And Emergency Surgery, 5(1), 791-796. doi: 10.32391/ajtes.v5i1.178

Bos, F., & Ruijs, A. (2021). Quantifying the Non-Use Value of Biodiversity in Cost–Benefit Analysis: The Dutch Biodiversity Points. Journal Of Benefit-Cost Analysis, 12(2), 287-312. doi: 10.1017/bca.2020.27

Bryant, A., Lawrie, T., & Fordham, E. (2021). Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. American Journal of Therapeutics, 28, e434–e460, July 2021. American Journal Of Therapeutics, 28(5), e573-e576. doi: 10.1097/mjt.0000000000001442

CZucman, N., Uhel, F., Descamps, D., Roux, D., & Ricard, J. (2021). Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2. Clinical Infectious Diseases. doi: 10.1093/cid/ciab129

Drupp, M., & Hänsel, M. (2021). Relative Prices and Climate Policy: How the Scarcity of Nonmarket Goods Drives Policy Evaluation. American Economic Journal: Economic Policy, 13(1), 168-201. doi: 10.1257/pol.20180760

Hariyanto, T., Halim, D., Rosalind, J., Gunawan, C., & Kurniawan, A. (2021). Ivermectin and outcomes from Covid‐19 pneumonia: A systematic review and meta‐analysis of randomized clinical trial studies. Reviews In Medical Virology. doi: 10.1002/rmv.2265

Hill, A., Garratt, A., Levi, J., Falconer, J., Ellis, L., & McCann, K. et al. (2021). Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection. Open Forum Infectious Diseases. doi: 10.1093/ofid/ofab358

Klompas, M. (2021). Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination. JAMA. doi: 10.1001/jama.2021.19063

Kory, P., Meduri, G., Varon, J., Iglesias, J., & Marik, P. (2021). Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. American Journal Of Therapeutics, 28(3), e299-e318. doi: 10.1097/mjt.0000000000001377

Kow, C., Merchant, H., Mustafa, Z., & Hasan, S. (2021). The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis. Pharmacological Reports, 73(5), 1473-1479. doi: 10.1007/s43440-021-00245-z

Marciniak, S., Farrell, J., Rostron, A., Smith, I., Openshaw, P., & Baillie, J. et al. (2021). COVID-19 pneumothorax in the UK: a prospective observational study using the ISARIC WHO clinical characterisation protocol. European Respiratory Journal, 58(3), 2100929. doi: 10.1183/13993003.00929-2021

Mukarram, M. (2021). Ivermectin Use Associated with Reduced Duration of Covid-19 Febrile Illness in a Community Setting. International Journal Of Clinical Studies And Medical Case Reports, 13(4). doi: 10.46998/ijcmcr.2021.13.000320

Okumuş, N., Demirtürk, N., Çetinkaya, R., Güner, R., Avcı, İ., & Orhan, S. et al. (2021). Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients. BMC Infectious Diseases, 21(1). doi: 10.1186/s12879-021-06104-9

Yeh, H. (2021). The Potential Declining Efficacy of the ChAdOx1 nCoV-19 Vaccine (AZD1222) on Inoculators With Nonsteroidal Anti-inflammatory Drug (NSAID) Intake. Clinical Infectious Diseases. doi: 10.1093/cid/ciab516

Zaidi, A., & Dehgani-Mobaraki, P. (2021). RETRACTED ARTICLE: The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article. The Journal Of Antibiotics. doi: 10.1038/s41429-021-00430-5

Additional Files

Published

2025-08-25

How to Cite

Pratama, A. P. ., Yerizam, M., & Syarif, A. (2025). Study on the Utilization of Egg Shells as CO2 Adsorbent in the Combustion Process of Empty Palm Fruit Bunches. International Journal of Research in Vocational Studies (IJRVOCAS), 5(2), 22–32. https://doi.org/10.53893/ijrvocas.v5i2.429